(Q40444722)

20 September 2017

title

Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine (English)

1 reference

20 September 2017

Lauren M Tatalick

1

1 reference

20 September 2017

Christopher J Gerard

2

1 reference

20 September 2017

Ryan Takeya

3

1 reference

20 September 2017

David N Price

4

1 reference

20 September 2017

Barbara A Thorne

5

1 reference

20 September 2017

Lisa M Wyatt

6

1 reference

20 September 2017

Pervin Anklesaria

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

23

1 reference

20 September 2017

issue

20

1 reference

20 September 2017

page(s)

2628-2638

1 reference

AAV-mediated gene transfer for hemophilia

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Evaluating virus-transformed cell tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

A rapid and efficient method for the detection of point mutations of the human prion protein gene (PRNP) by direct sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Human prion diseases and bovine spongiform encephalopathy (BSE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Prion diseases and the BSE crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Complete genomic sequence and analysis of the prion protein gene region from three mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Biopsy diagnosis of Creutzfeldt-Jakob disease by western blot: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

Stability of the prion protein-encoding (PRNP) gene in HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.027

10.1016/J.VACCINE.2004.11.027

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference